Annexin V-Cy5 Apoptosis Staining / Detection试剂盒(ab14150)
Key features and details
- Assay type: Direct
- Platform: Flow cytometer, Fluorescence microscope
- Assay time: 10 min
- Sample type: Adherent cells, Suspension cells
概述
-
产品名称
Annexin V-Cy5 Apoptosis Staining / Detection试剂盒
参阅全部 Annexin V/ANXA5 试剂盒 -
样品类型
Adherent cells, Suspension cells -
检测类型
Direct -
检测时间
0h 10m -
产品概述
Annexin V-Cy5 Apoptosis Staining / Detection Kit ab14150 is used in a 10 min, one-step staining procedure to detect apoptosis by staining phosphatidylserine molecules which have translocated to the outside of the cell membrane.
Fluorescence can be detected at Ex/Em = 649/670 nm.
Analysis is by flow cytometry or fluorescence microscopy.
The Annexin V-Cy5 reagent contained in the kit is also available as Annexin V-Cy5 reagent ab14147.
-
说明
This product is manufactured by BioVision, an Abcam company and was previously called K103 Annexin V-Cy5 Apoptosis Kit. K103-100 is the same size as the 100 test size of ab14150.
Soon after initiating apoptosis, cells translocate membrane phosphatidylserine molecules from the inner face of the plasma membrane to the cell surface. Phosphatidylserine on the cell surface is detected by staining with a fluorescent conjugate of Annexin V, a protein that has a high affinity for phosphatidylserine.
For more apoptosis assays, review the full set of Annexin V assays, or the apoptosis assay and apoptosis marker guide.
-
平台
Flow cytometer, Fluorescence microscope
性能
-
存放说明
Store at +4°C. Please refer to protocols. -
组件 100 tests Annexin V-Cy5 1 x 500µl Binding Buffer II 1 x 50ml -
研究领域
-
功能
This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade. -
疾病相关
Pregnancy loss, recurrent, 3 -
序列相似性
Belongs to the annexin family.
Contains 4 annexin repeats. -
结构域
The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex.
A pair of annexin repeats may form one binding site for calcium and phospholipid. -
翻译后修饰
S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex. - Information by UniProt
-
别名
- Anchorin CII
- Annexin 5
- Annexin A5
see all
相关产品
-
Related Products
- FCCP, mitochondrial oxidative phosphorylation uncoupler (ab120081)
- Cycloheximide, Protein synthesis inhibitor (ab120093)
- SB431542, ALK inhibitor (ab120163)
- Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (ab120382)
- Z-VAD(OMe)-FMK, Cell permeable, irreversible pan-caspase inhibitor (ab120487)
- Doxorubicin hydrochloride, Topoisomerase II inhibitor (ab120629)
- Dorsomorphin (Compound C), AMP-kinase inhibitor (ab120843)
- Annexin V/ANXA5-FITC Apoptosis Detection Reagent (500X) (ab14082)
- Propidium Iodide (ab14083)
- 10X Annexin V/ANXA5 Binding Buffer (ab14084)
- Annexin V-FITC Apoptosis Staining / Detection Kit (ab14085)
- Calcein AM, fluorescent dye for cell viability (ab141420)
- Annexin V-Cy3 Apoptosis Staining / Detection Kit with SYTOX (ab14144)
- Annexin V/ANXA5-Cy5 Apoptosis Staining / Detection Reagent (ab14147)
- Annexin V-Cy5 Apoptosis Staining / Detection Kit (ab14150)
- Annexin V-EGFP Apoptosis Staining / Detection Kit (ab14153)
图片
数据表及文件
-
SDS download
-
Datasheet download
文献 (26)
ab14150 被引用在 26 文献中.
- Li P et al. LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy. EMBO Mol Med 14:e14511 (2022). PubMed: 34779136
- Lu J et al. In vitro assessment of an engineered tBID-based safety switch system in human T lymphocytes. Ann Transl Med 9:1641 (2021). PubMed: 34988150
- Voigt S et al. A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation. Nat Commun 11:685 (2020). PubMed: 32019925
- Veetil AT et al. DNA-based fluorescent probes of NOS2 activity in live brains. Proc Natl Acad Sci U S A 117:14694-14702 (2020). PubMed: 32554491
- Marcar L et al. Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity. Cell Rep 27:3422-3432.e4 (2019). PubMed: 31216465